• Your shopping cart is empty!

  • CLSI M57-Ed1 (R2022)

CLSI M57-Ed1 (R2022)

Principles and Procedures for the Development of Epidemiological Cutoff Values for Antifungal Susceptibility Testing

Clinical and Laboratory Standards Institute, 04/25/2016

Publisher: CLSI

File Format: PDF

$90.00$180.00


Published:25/04/2016

Pages:28

File Size:1 file , 2 MB

Note:This product is unavailable in Russia, Belarus

This guideline includes the criteria for developing and using epidemiological cutoff values for guiding clinical decisions when testing fungal species and antifungal agent combinations for which there are no breakpoints.

More CLSI standard pdf

CLSI M31A3

CLSI M31A3

Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacterial Isolated from Animals; Approved Standard, M31-A3

$137.00 $275.11

CLSI VET02-A3

CLSI VET02-A3

Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters for Veterinary Antimicrobial Agents; Approved Guideline - Third Edition, VET02A3E

$90.00 $180.00

CLSI I/LA30-A

CLSI I/LA30-A

Immunoassay Interference by Endogenous Antibodies; Approved Guideline, ILA30AE

$108.00 $216.21

CLSI M23-A3

CLSI M23-A3

Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters; Approved Guideline--Third Edition, M23A3E

$145.00 $290.74